41-50 of 66 articles
-
Editor's Pick!0Selection of API CDMO - Part 3/3The primary objective of this article is to introduce the reader to the process of identifying, selecting, negotiat...
-
Target marketJapan, USA, Other countries
-
Business categoryPharmaceutical, Biopharmaceutical, Others
-
Business functionClinical development > CRO selection, Engineering, production, GMP > , Business consulting >
-
Author"Nelson M Lugo" of "Nelson M Lugo Consulting"
-
AvailabilityMembership
-
-
Not Subscribed1(米国eHealthジャーナル) 第１号
-
Target marketUSA
-
Business categoryMedical device, Digital health
-
Business functionMarketing >
-
Author"LSMIP Editorial Office" of "CM Plus Singapore Pte. Ltd."
-
AvailabilityJournal
-
-
0Selection of API CDMO - Part 2/3The primary objective of this article is to introduce the reader to the process of identifying, selecting, negotiat...
-
Target marketJapan, USA, Other countries
-
Business categoryPharmaceutical, Biopharmaceutical, Others
-
Business functionClinical development > CRO selection, Engineering, production, GMP > , Business consulting >
-
Author"Nelson M Lugo" of "Nelson M Lugo Consulting"
-
AvailabilityMembership
-
-
0Selection of API CDMO - Part 1/3The primary objective of this article is to introduce the reader to the process of identifying, selecting, negotiat...
-
Target marketJapan, USA, Other countries
-
Business categoryPharmaceutical, Biopharmaceutical, Others
-
Business functionClinical development > CRO selection, Engineering, production, GMP > , Business consulting >
-
Author"Nelson M Lugo" of "Nelson M Lugo Consulting"
-
AvailabilityMembership
-
-
Editor's Pick!0Identifying Product Value When Entering the US Biopharma Market
-
Target marketUSA
-
Business categoryPharmaceutical, Biopharmaceutical, Regerative medicine, Medical device
-
Business functionMarketing > , Clinical development > , Business consulting >
-
Author"Joachim Osther" of "Berea BioVentures, LLC"
-
AvailabilityMembership
-
-
-
0Verily、大塚製薬など製薬大手4社と提携(ジャーナル試読版｜第３号)臨床研究の変革を目的として、大塚製薬、Novartis、、Pfizer、Sanofiの製薬大手4社と戦略的提携契約を締結したと発表した。
-
Target marketUSA
-
Business categoryDigital health
-
Business function
-
Author"Yukako Goshima" of "MSA Partners, LLC"
-
AvailabilityMembership
-
-
0自閉症発症に非コード遺伝子変異が関係(ジャーナル試読版｜第３号)AIを使った深層学習アプローチによって、自閉症の発症に非コード遺伝子変異が関連している様子を明らかにした研究結果が発表された。
-
Target marketUSA
-
Business categoryDigital health
-
Business function
-
Author"Yukako Goshima" of "MSA Partners, LLC"
-
AvailabilityMembership
-
-
0Express Scripts、デジタルヘルス・フォーミュラリー導入へ(ジャーナル試読版｜第３号)薬剤給付管理会社（PBM）大手のExpress Scriptsは、2020年からデジタルヘルスのみを扱うデジタルヘルス・フォーミュラリーを導入すると発表した。
-
Target marketUSA
-
Business categoryDigital health
-
Business function
-
Author"Yukako Goshima" of "MSA Partners, LLC"
-
AvailabilityMembership
-
-
0Garmin InternationalとBCBSが提携(ジャーナル試読版｜第３号)Garmin Internationalは5月29日、Blue Cross Blue Shield Association（BCBS）と提携したと発表した。
-
Target marketUSA
-
Business categoryDigital health
-
Business function
-
Author"Yukako Goshima" of "MSA Partners, LLC"
-
AvailabilityMembership
-
-
0Altoida、シリーズA投資ラウンドで630万ドルを調達(ジャーナル試読版｜第３号)AIと機械学習を利用してアルツハイマー型認知症を予測するデジタル・バイオマーカーを開発するAltoidaは、630万ドルを調達したと発表した。
-
Target marketUSA
-
Business categoryDigital health
-
Business function
-
Author"Yukako Goshima" of "MSA Partners, LLC"
-
AvailabilityMembership
-
-
What information are you looking for in articles?
Let us help you to find out the articles for your business requirements!
Let us help you to find out the articles for your business requirements!